Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Cash from Operations (2019 - 2026)

Atea Pharmaceuticals' Cash from Operations history spans 8 years, with the latest figure at 46391000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 51.79% to 46391000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 147859000.0 through Mar 2026, down 17.17% year-over-year, with the annual reading at 132031000.0 for FY2025, 2.56% up from the prior year.
  • Cash from Operations came in at 46391000.0 for Q1 2026, down from 28223000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 16120000.0 in Q2 2023 to a low of 59009000.0 in Q1 2022.
  • The 5-year median for Cash from Operations is 29850000.0 (2023), against an average of 30605764.71.
  • The largest YoY upside for Cash from Operations was 71.43% in 2022 against a maximum downside of 250.47% in 2022.
  • Atea Pharmaceuticals' Cash from Operations stood at 21545000.0 in 2022, then decreased by 1.34% to 21834000.0 in 2023, then tumbled by 39.22% to 30397000.0 in 2024, then grew by 7.15% to 28223000.0 in 2025, then crashed by 64.37% to 46391000.0 in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Cash from Operations are 46391000.0 (Q1 2026), 28223000.0 (Q4 2025), and 40375000.0 (Q3 2025).